STAT has a blockbuster team of reporters covering every major health care industry in the United States, from pharma, biotech, hospitals, insurance, health tech to medical devices.
They focus on breaking news, investigations, and features about the ways money is shaping medicine, from early investments in research to pricing and regulatory decisions that shape a company’s finances.
To get the latest health care business news delivered to your inbox, sign up for our free, weekly newsletter on the business of health care, STAT’s Health Care Inc.. Or you can sign up for our daily newsletter on biotech, The Readout, or our twice-weekly Health Tech newsletter. And subscribe to STAT+ for inside intelligence on the life sciences, health policy, health tech developments, and biopharma.
Medicare Advantage insurers could face an average 2.3% cut to payments in 2024, or a net cut of more than $3 billion, if the government proposal stands.
Read The Story
Medtech innovation generally happens out of the limelight yet has an enormous impact on public health and offers significant investment opportunities.
Read The StoryOut of the roughly 200 countries in the entire world, the U.S. is one of just two that allows drug companies to advertise on TV. Why?
Read The Story
advertisement
